This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Acer Therapeutics Inc. The contract, valued at up to $225,000, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The contract has a period of performance from January 1, 2024 to December 31, 2028. The VA, through its Veterans Integrated Service Network 12, is the funding agency for this contract. As an FSS contract, it is a multiple award...
This contract is a Federal Supply Schedule (FSS) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Acer Therapeutics Inc. The FSS is a Type of Indefinite Delivery Vehicle (IDV) that provides federal agencies access to commercial products and services at pre-negotiated prices, terms, and conditions. The contract is for Schedule 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Acertis Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The $25,000.00 contract is an interim agreement under FSS Schedule 65 I B, which covers drugs, pharmaceuticals, and hematology-related products. It has a period of performance ending on September 28, 2023. The contract does not use any set-asides and is a multiple...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
The Federal Supply Schedule (FSS) contract 36F79720D0115 was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Secura Bio, Inc., a for-profit manufacturer, on April 1, 2020. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule and has a ceiling value of $250,000.00. It is a multiple award contract with no set-asides, and the period of performance runs through September 30, 2025. The purpose of the contract is to provide drugs,...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is a $200,000.00 interim agreement with Amarin Pharma, Inc. to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. The contract has an ultimate completion date of August 30, 2024 and was awarded on March 5, 2024 without any set-aside requirements. The purpose of this multiple-award FSS contract is to...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), provides Supernus Pharmaceuticals, Inc. a five-year, $132.6 million ceiling to supply drugs, pharmaceuticals, and hematology-related products to VA medical facilities. As a multiple award schedule (MAS) contract under FSS-61-IB, it allows the VA to directly order pre-negotiated products from Supernus's catalog to efficiently meet the...